Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2989 USD | +2.64% |
|
+6.37% | -61.87% |
Jun. 17 | Ladenburg Downgrades Coeptis Therapeutics to Neutral From Buy | MT |
Jun. 14 | Coeptis Therapeutics Holdings, Inc. announced that it has received $4.3 million in funding | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.87% | 10.81M | |
+62.77% | 841B | |
+40.42% | 625B | |
-3.94% | 360B | |
+17.39% | 327B | |
+10.47% | 300B | |
+15.66% | 242B | |
+17.90% | 227B | |
+15.76% | 174B | |
+0.85% | 162B |
- Stock Market
- Equities
- COEP Stock
- News Coeptis Therapeutics Holdings, Inc.
- Coeptis Therapeutics Gets Exclusive Right to Negotiate Deal With Deverra Therapeutics